Catalyst Wire Dossier Catalyst Wire Dossier

GL2907 XL

· GL Pharm Tech Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GL2907 XL, covering 2013-01-28 to 2013-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers [Phase 1]

See pricing